Founded in 1998, Gan & Lee Pharmaceuticals has successfully developed the first Chinese domestic insulin analog. The company has become one of the main suppliers of insulin in China and now strives to broaden its global coverage in the field of diabetes diagnosis and treatment. Headquartered in the Tongzhou Economic Development Area, Beijing, China, Gan & Lee has state-of-the-art buildings and GMP facilities. In 2014, it established a US subsidiary in New Jersey, and in 2019, Gan & Lee selected Linyi City, Shandong, China, to become its second domestic drug production site, with further plans to expand to North America, Europe, and other regions. Gan & Lee is committed to providing solutions to patients across the globe and providing a positive impact on patient lives. Our clinical development program is investigating new chemical entities and biologics to treat cardiovascular disease, metabolic disease, cancer and diseases in other therapeutic areas.
View Top Employees from Gan & Lee PharmaceuticalsWebsite | http://www.ganlee.com/en |
Revenue | $7 million |
Funding | $363.8 million |
Employees | 472 (158 on RocketReach) |
Founded | 1998 |
Address | 通州区漷县 8 镇南凤西一路, Beijing, CN |
Phone | +86 10 8059 3628 |
Technologies |
JavaScript,
HTML,
Google Analytics
+10 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Manufacturing General, Biopharma, Insulin biosimilars, Manufacturing, Biotechnology, Medical device, Health Care, Pharmaceutical R&D, Science and Engineering, Medical, Pharmaceutical |
Web Rank | 8 Million |
Keywords | Diabetes Medication, Cardiovascular Services, Cancer Treatment, Therapeutic Activities, Biologics, Clinical Development |
SIC | SIC Code 28 Companies, SIC Code 80 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541711 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies |
Looking for a particular Gan & Lee Pharmaceuticals employee's phone or email?
The Gan & Lee Pharmaceuticals annual revenue was $7 million in 2024.
Wenjun Wu is the Director, Bioprocess Development of Gan & Lee Pharmaceuticals.
158 people are employed at Gan & Lee Pharmaceuticals.
The NAICS codes for Gan & Lee Pharmaceuticals are [5417, 54171, 541711, 541, 54].
The SIC codes for Gan & Lee Pharmaceuticals are [28, 80, 283].